Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$47,466.27
Jan 1, 2021
International (non-government)
Grants to International Affiliations - IAU
A1-011192-01-01
Membership to IAU allows Canada to participate in international endeavours and promotes the exchange and dissemination of knowledge in the most advanced areas of scientific and industrial research.
$12,728.79
Jan 1, 2021
International (non-government)
Grants to International Affiliations - URSI
A1-011192-01-01
Membership toURSI allows Canada to participate in international endeavours and promotes the exchange and dissemination of knowledge in the most advanced areas of scientific and industrial research.
$3,483.09
Jan 1, 2021
International (non-government)
Grants to International Affiliations - IUPS
A1-011192-01-01
Membership to IUPS allows Canada to participate in international endeavours and promotes the exchange and dissemination of knowledge in the most advanced areas of scientific and industrial research.
$25,265.97
Jan 1, 2021
International (non-government)
Grants to International Affiliations - IUGG
A1-001192-01-01
Membership to IUGG allows Canada to participate in international endeavours and promotes the exchange and dissemination of knowledge in the most advanced areas of scientific and industrial research.
$250,000.00
Jan 1, 2021
Individual or sole proprietorship
Op Gr: Eval of Harm Reduct. Appro. Address the Opioid Crisis - SCS Eval. Ontario
158901
The specific objectives of this funding opportunity are to:
• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
$213,762.00
Jan 1, 2021
Individual or sole proprietorship
Op Gr: Eval of Harm Reduct. Appro. Address the Opioid Crisis -SCS Eval. Prairies
158900
The specific objectives of this funding opportunity are to:
• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
$249,900.00
Jan 1, 2021
Individual or sole proprietorship
Op Gr: Eval of Harm Reduct. Appro. Address the Opioid Crisis -SCS Eval QC-Atlan.
158902
The specific objectives of this funding opportunity are to:
• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
$249,065.00
Jan 1, 2021
Individual or sole proprietorship
Op Gr: Eval of Harm Reduct. Appro. Address the Opioid Crisis - SCS Evaluation BC
158899
The specific objectives of this funding opportunity are to:
• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
$2,096,137.00
Jan 1, 2021
Individual or sole proprietorship
Op Gr: Eval of Harm Reduct. Appro. Address the Opioid Crisis - Safer Supply Eval
158898
The specific objectives of this funding opportunity are to:
• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy
$49,358.78
Jan 1, 2021
International (non-government)
Grants to International Affiliations - EUREKA - EUROSTARS-2 Programme
A1-011192-01-01
Membership to EUREKA - EUROSTARS-2 Programme allows Canada to participate in international endeavours and promotes the exchange and dissemination of knowledge in the most advanced areas of scientific and industrial research.